RSV 2005: Global impact, changing concepts, and new challenges.
Openshaw
Peter J M
PJ
Department of Respiratory Medicine, Imperial College, London, United Kingdom. p.openshaw@imperial.ac.uk
Tregoning
John
J
Harker
James
J
D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D022261:Respiratory Syncytial Virus Vaccines; D012136:Respiratory Syncytial Viruses / Q000276:immunology / Q000502:physiology
D000998:Antiviral Agents; D022261:Respiratory Syncytial Virus Vaccines